Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
13-06-2024
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
13-06-2024
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Filing of Annual Report in Form 20F for the fiscal year ended 31 March, 2024 with United States Securities and Exchange Commission
13-06-2024
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
12-06-2024
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Issue of Letter of confirmation in lieu of share certificate(s) reported lost/misplaced
12-06-2024

US Health Regulator Flags Four Observations At Dr Reddy's API Unit

The USFDA today completed a GMP inspection at the company's API manufacturing facility (CTO-6) in Srikakulam.
08-06-2024
Next Page
Close

Let's Open Free Demat Account